valeant pharmaceuticals inte
(VRX:Toronto)
Executive Profile*
J. Michael PearsonChairman of the Board and Chief Executive Officer, Valeant Pharmaceuticals International, Inc. |
| Age | Total Calculated Compensation | This person is connected to 22 board members in 5 different organizations across 5 different industries. See Board Relationships |
| 52 | $6,112,975 As of Fiscal Year 2012 |
Background*
Mr. J. Michael Pearson, Mike has been the Chief Executive Officer and President of Obagi Medical Products, Inc. since April 25, 2013. Mr. Pearson served as the Chief Executive Officer of Valeant Pharmaceuticals International Inc. at Eyetech Inc. since September 2010. Mr. Pearson joined Valeant in February 2008 as Chairman and Chief Executive Officer. Prior to joining Valeant, Mr. Pearson served as the Head of the Global Pharmaceutical Practice and Head of mid-Atlantic ...
Corporate Headquarters*2150 St. Elzéar boulevard WestLaval, Quebec H7L 4A8 Canada Phone: 514-744-6792 Fax: 514-744-6272 Board Members Memberships*Director and Head of Global Pharmaceutical Practice and Head of Mid-Atlantic Region 2008-N/A Former Chairman and Chief Executive Officer 2010-Present Chairman of the Board and Chief Executive Officer 2013-Present Chief Executive Officer, President and Director
Education*BS Duke University BSE Duke University MBA University of Virginia
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| VRX:CN | C$88.64 CAD | +0.90 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Paul M. Bisaro | Chief Executive Officer, President and Director Actavis, Inc. | $2.4M |
| Dilip Shantilal Shanghvi | Managing Director, Promoter executive Director and Member of Shareholders/Investors Grievance Committee Sun Pharmaceutical Industries Limited | -- |
| David E. I. Pyott | Chairman, Chief Executive Officer and President Allergan Inc. | $1.3M |
| Howard Solomon | Chairman, Chief Executive Officer and President Forest Laboratories Inc. | $2.4M |
| Flemming Ornskov M.D., MBA, MPH | Chief Executive Officer, Head of Human Genetic Therapies and Director Shire plc | -- | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Bridgewater, MA | Valeant PharmaceuticalsPosted: Jun 16
- Bridgewater, MA | Valeant PharmaceuticalsPosted: Jun 16
- Scottsdale, AZ | Valeant PharmaceuticalsPosted: May 24
- New Jersey | Valeant PharmaceuticalsPosted: May 14
Sponsored Financial Commentaries
Sponsored Links
To contact VALEANT PHARMACEUTICALS INTE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
